{
  "trial_id": "NCT02129348",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Male and female adults",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Diagnosis of possible or probable AD by standard NIA criteria (McKahnn et al, 1984; McKhann et all, 2011)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Folstein MMSE 5-26 out of 30",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Neuropsychiatric Inventory (NPI) agitation/aggression subscale score > 4",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Female patients need to be post-menopausal",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Availability of informant; patients without an informant will not be recruited",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Patients who lack capacity must have a surrogate",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Medical contraindication to lithium treatment or prior history of intolerability to lithium treatment",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Contraindications to lithium in this study include: resting tremor causing functional impairment, history of falls in the last month, untreated thyroid disease or any abnormal thyroid function test (T3, T4, or TSH), creatinine level greater than 1.5 mg/100ml or a glomerular filtration rate less than 44ml/min/ 1.73m2; blood pressure > 150/90 mm Hg; heart rate < 50 bpm; unstable cardiac disease based on history, physical examination, and ECG",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Medications, in combination with lithium, known to have adverse renal effects, including therapeutic or higher doses of diuretics, i.e. hydrochlorothiazide greater than 25mg daily or furosemide greater than 10mg daily",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Current clinical diagnosis of schizophrenia, schizoaffective disorder, other psychosis, or bipolar 1 disorder (DSM-IV TR criteria)",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Current or recent (past 6 months) alcohol or substance dependence (DSM-IV TR criteria)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current major depression or suicidality as assessed by the study psychiatrist",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Suicidal behavior or dangerous behavior with serious safety risk or risk of physical harm to self or others",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of CAD, CHF, obesity hypoventilation syndrome, obstructive sleep apnea, DM2, ventricular tachycardia, hypothyroidism, schizophrenia, COPD, and Pneumonia. However, they do not have any contraindications to lithium treatment or prior history of intolerability to lithium treatment.",
  "_meta": {
    "topic_id": "14",
    "trial_id": "NCT02129348",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}